The case of a 1 month-old boy with a severe form of Thomsen-Becker myotonia is reported. Resistance to regular antimyotonic treatment over a 3 month-period of time led to use mexiletine, an antiarrhythmic drug. This treatment was responsible for a dramatic clinical and electromyographic improvement. No adverse effect has been observed over a 16 month-period of continuous treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[value mexiletine
4
treatment
4
mexiletine treatment
4
treatment thomsen-becker
4
thomsen-becker myotonia]
4
myotonia] case
4
case month-old
4
month-old boy
4
boy severe
4
severe form
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!